Another death claim refuted by PGI

Tribune News Service

Updated At : 01:03 PM Oct 18, 2022 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

Chandigarh, October 17

Amid reports of death of a chronic liver patient after giving Terlipressin injection, the PGI authorities refuted the claim, saying of five patients who received the injection to treat hepatorenal syndrome (when kidneys stop working well in patients with serious liver problems) and developed skin necrosis, four were also getting other vasoconstrictors such as noradrenaline.

“Also they had other factors like low blood pressure, infections. These were patients with acute chronic liver failure and uncompensated cirrhosis with liver cancer. Some were on ventilator and inotrope to maintain blood pressure. Therefore, it is very difficult to pinpoint a single drug or factor that would have caused skin necrosis. Possibly it will be multifactorial,” they claimed.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles